These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Kochhar S; Assis DN; Mack C; Izurieta HS; Muratori L; Munoz A; Nordenberg D; Gidudu JF; Blau EF; Vierling JM Vaccine; 2024 Mar; 42(7):1812-1825. PubMed ID: 38368225 [TBL] [Abstract][Full Text] [Related]
14. Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Woerner A; Pourmalek F; Panozzo C; Pileggi G; Hudson M; Caric A; Abraham S; Varricchio F; Velasco C; Oleske J; Bauwens J; Bonhoeffer J; Vaccine; 2019 Jan; 37(2):384-391. PubMed ID: 30342899 [No Abstract] [Full Text] [Related]
15. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Sejvar JJ; Kohl KS; Bilynsky R; Blumberg D; Cvetkovich T; Galama J; Gidudu J; Katikaneni L; Khuri-Bulos N; Oleske J; Tapiainen T; Wiznitzer M; Vaccine; 2007 Aug; 25(31):5771-92. PubMed ID: 17570566 [No Abstract] [Full Text] [Related]
16. Acute wheeze in the pediatric population: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Katz MA; Marangu D; Attia EF; Bauwens J; Bont LJ; Bulatovic A; Crane J; Doroshenko A; Ebruke BE; Edwards KM; Fortuna L; Jagelaviciene A; Joshi J; Kemp J; Kovacs S; Lambach P; Lewis KDC; Ortiz JR; Simões EAF; Turner P; Tagbo BN; Vaishnavi V; Bonhoeffer J; Vaccine; 2019 Jan; 37(2):392-399. PubMed ID: 28483201 [No Abstract] [Full Text] [Related]
17. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B; Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547 [TBL] [Abstract][Full Text] [Related]
18. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705 [TBL] [Abstract][Full Text] [Related]
19. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Gershman MD; Staples JE; Bentsi-Enchill AD; Breugelmans JG; Brito GS; Camacho LA; Cottin P; Domingo C; Durbin A; Gascon J; Guenaneche F; Hayes EB; Jelenik Z; Khromava A; Martins Rde M; Wilson MM; Massy N; Nasidi A; Niedrig M; Sherwat A; Tsai T; Vilella A; Wilson ME; Kohl KS; Vaccine; 2012 Jul; 30(33):5038-58. PubMed ID: 22561144 [No Abstract] [Full Text] [Related]
20. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries. Watson G; Dodd C; Munoz FM; Eckert LO; Jones CE; Buttery JP; Yildirim IB; Kachikis A; Heath PT; Schlaudecker EP; Bond NH; Santarcangelo PL; Wilcox CR; Bellamy K; Elmontser M; Sienas L; Simon R; Khalil A; Townsend R; Sturkenboom M; Black S Pediatr Infect Dis J; 2021 Dec; 40(12):1127-1134. PubMed ID: 34596623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]